Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282
Open Access
- 1 August 2001
- journal article
- clinical trial
- Published by Elsevier BV in Annals of Oncology
- Vol. 12 (8), 1139-1143
- https://doi.org/10.1023/a:1011632713360
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors: A study by the Italian Trials in Medical Oncology groupCancer, 1996
- Mitoxantrone in metastatic apudomas: a phase II study of the EORTC Gastro-Intestinal Cancer Cooperative GroupBritish Journal of Cancer, 1995
- A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumorsCancer, 1994
- Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a: A study by the Italian trials in Medical Oncology GroupCancer, 1993
- A phase II trial of carboplatin in patients with advanced APUD tumorsCancer, 1993
- Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study.Journal of Clinical Oncology, 1992
- Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1992
- Metastatic carcinoid and islet cell tumours of the pancreas: A phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatinEuropean Journal of Cancer and Clinical Oncology, 1991
- Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1980